Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
806
+50
+7% +$21K 0.24% 98
2026
Q1
$286K Buy
756
+10
+1% +$4.28K 0.2% 113
2025
Q4
$319K Sell
746
-78
-9% -$34K 0.22% 106
2025
Q3
$369K Buy
824
+39
+5% +$17.7K 0.23% 107
2025
Q2
$382K Sell
785
-30
-4% -$17.1K 0.26% 101
2025
Q1
$501K Buy
815
+18
+2% +$10.2K 0.33% 92
2024
Q4
$422K Buy
797
+249
+45% +$140K 0.27% 104
2024
Q3
$329K Buy
548
+20
+4% +$11.3K 0.22% 123
2024
Q2
$286K Buy
+528
New +$302K 0.2% 125
2023
Q3
Sell
-387
Closed -$210K 180
2023
Q2
$210K Hold
387
0.17% 174
2023
Q1
$208K Buy
+387
New +$197K 0.16% 179
2022
Q1
Sell
-390
Closed -$206K 200
2021
Q4
$206K Buy
+390
New +$187K 0.14% 195
2021
Q3
Sell
-479
Closed -$227K 184
2021
Q2
$227K Sell
479
-5
-1% -$2.4K 0.17% 163
2021
Q1
$222K Sell
484
-49
-9% -$24K 0.18% 161
2020
Q4
$284K Buy
+533
New +$262K 0.23% 137

Other funds holding CHE

Renasant Bank's CHE Position: Q2 2026 in Review

Renasant Bank increased its Chemed (CHE) stake by 6.6% in Q2 2026, buying an estimated $21K and bringing the position to 806 shares worth $375K. The position accounts for 0.24% of the portfolio, ranked #98.

Renasant Bank first reported a position in CHE in Q4 2020 and has held it in 15 quarters since. The position peaked at $501K in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Renasant Bank held 806 shares of Chemed worth $375K as of Q2 2026.
  • Renasant Bank bought 50 Chemed shares in Q2 2026, an estimated $21K.
  • Chemed made up 0.24% of Renasant Bank's portfolio in Q2 2026, its #98 holding.
  • Renasant Bank first reported a position in Chemed in Q4 2020 and has held it in 15 quarters since.
  • Renasant Bank's Chemed position peaked at $501K in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Renasant Bank's 13F filing for Q2 2026, filed 11 Aug 2026.